Arbutus Biopharma (ABUS) P/E (2015 - 2026)
Arbutus Biopharma (ABUS) P/E from Aug 3, 2015 to Jul 21, 2026. The TTM Arbutus Biopharma (ABUS) P/E is 5.55. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Arbutus Biopharma (ABUS)
| Year | P/E | Change |
|---|---|---|
| 2026 | 5.55 | -120.16% |
| 2025 | -27.52 | +214.82% |
| 2024 | -8.74 | +60.98% |
| 2023 | -5.43 | +7.99% |
| 2022 | -5.03 | -10.89% |
| 2021 | -5.64 | +35.59% |
| 2020 | -4.16 | +306.91% |
| 2019 | -1.02 | -72.49% |
| 2018 | -3.72 | +258.35% |
| 2017 | -1.04 | +33.19% |
| 2016 | -0.78 | -79.83% |
| 2015 | -3.86 | N/A |
Comparison Arbutus Biopharma (ABUS) P/E with competitors
Arbutus Biopharma (ABUS) P/E is 5.55.